BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 9, 2015
View Archived Issues
Deciphera initiates phase I trial of KIT and PDGFR inhibitor DCC-2618
Read More
Copernicus receives FDA orphan drug designation for ABCA4 DNA nanoparticles
Read More
Takeda reflects on accomplishments of second quarter of fiscal 2015
Read More
InMed provides update on development program for epidermolysis bullosa
Read More
Allergan licenses dry eye candidate MIM-D3 from Mimetogen
Read More
Cel-Sci's RA vaccine selected for NIH commercialization and niche analysis plan
Read More
NIH grant supports City of Hope's research into chronic GvHD
Read More
Janssen initiates phase Ib trial of subcutaneous daratumumab in multiple myeloma
Read More
Preclinical toxicity study results for Pyridorin will support planned IND filing
Read More
New companies created: Evelo Therapeutics, Aziyo Biologics and Iron Horse Therapeutics
Read More
Global Health Innovative Technology Fund announces grants for infectious disease research
Read More
Ono Pharmaceutical presents update on second quarter of fiscal 2015
Read More
SUL-121, a novel candidate to treat diabetic nephropathy
Read More
Eisai begins two joint research agreements to develop new antimalarial medicines
Read More
IND gets submitted for TD-1473 gastrointestinal-targeted pan-JAK inhibitor from Theravance
Read More
New antimalarial strategy shows promising preclinical results
Read More
RSV vaccine candidate shows promise for children
Read More
Novartis reports autotaxin inhibitors
Read More
Gruenenthal patents dual cathepsin K and S inhibitors
Read More
HEC Pharm presents PDE4B inhibitors
Read More
China State Institute of Pharmaceutical Industry introduces podophyllotoxin derivatives
Read More
Australian team divulges Nix-based gene therapies for neurodegeneration
Read More
Ignyta licenses rights to Lilly's taladegib oncology program
Read More
Antagonism of CCR2/5 in type 2 diabetic nephropathy
Read More
Neurocrine starts phase I trial of essential tremor candidate NBI-640756
Read More
Transgenomic launches mutation profiling test for NSCLC
Read More
FDA accepts for review Amgen's NDA for etelcalcetide
Read More
Preliminary phase II results presented for a malaria vaccine adjuvant
Read More